Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03440450
What this trial is testing

Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer

Who this might be right for
Advanced Solid TumorsBiliary Tract Cancer
Fujifilm Pharmaceuticals U.S.A., Inc. 90
Not applicableLooking for participantsNCT07195513
What this trial is testing

Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services

Who this might be right for
Palliative Care ReferralAdvanced CancerPalliative Care, Health Services+1 more
Dartmouth-Hitchcock Medical Center 90
Testing effectiveness (Phase 2)Looking for participantsNCT06117540
What this trial is testing

WX390 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd 70
Not applicableStudy completedNCT04431830
What this trial is testing

Meaning-Centered Pain Coping Skills Training

Who this might be right for
Advanced Solid TumorPain
Duke University 60
Early research (Phase 1)Study completedNCT05508100
What this trial is testing

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immune-Onc Therapeutics 38
Early research (Phase 1)Study completedNCT01905111
What this trial is testing

BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Early research (Phase 1)Study completedNCT04060511
What this trial is testing

HS-10342 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 17
Not applicableEnded earlyNCT05471271
What this trial is testing

IL-2 PET Imaging in Advanced Solid Tumours

Who this might be right for
Metastatic Solid Tumor
University Medical Center Groningen 1
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT05017012
What this trial is testing

Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)

Who this might be right for
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC 142
Early research (Phase 1)Looking for participantsNCT05458219
What this trial is testing

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 470
Early research (Phase 1)UnknownNCT03645200
What this trial is testing

Treatment of Carrying TP53 Harmful Mutations

Who this might be right for
Advanced Cancer
Tianjin Medical University Second Hospital 60
Early research (Phase 1)Study completedNCT02834611
What this trial is testing

Ceramide NanoLiposome in Patients With Advanced Solid Tumors

Who this might be right for
CancerCarcinomaSolid Tumors+1 more
Keystone Nano, Inc 14
Early research (Phase 1)Ended earlyNCT01496534
What this trial is testing

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsBladder Cancer
Matthew Galsky 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053
What this trial is testing

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Who this might be right for
Rare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Early research (Phase 1)Study completedNCT03089645
What this trial is testing

MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 39
Early research (Phase 1)Looking for participantsNCT06607939
What this trial is testing

ORB-021 In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
Orionis Biosciences Inc 36
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Next Page